identified as a primary mechanism for apoptosis in cells genetically engineered to overexpress AIF (Loeffler et al., 2001; Susin et al., 1999) , cells deficient in caspase-3 or the caspase accessory molecule Apaf-1 (Joza et al., 2001; or with exogenous caspase inhibition (Dumont et al., 2000; Yasugi et al., 2000) . AIF also translocates to the nucleus in retinal photoreceptors following retinal detachment (Hisatomi et al., 2001) .
In this report, we demonstrate that primary RPE cells under conditions of oxidant-induced cell death undergo mitochondrial depolarization with subsequent release of cytochrome c but without subsequent caspase-9, -3, PARP cleavage or 200 bp DNA fragmentation. However, under this lethal condition, cells exhibit membrane blebbing and AIF release, which results in large-scale DNA fragmentation. Furthermore, AIF release can be inhibited by pre-treatment with hepatocyte growth factor/scatter factor (HGF/SF), with a resulting increase in cell survival. These data indicate that under certain conditions, primary cells use AIF release as a principle mechanism for cell death, and highlights the potential limitation of caspase-inhibitory therapies for degenerative disorders.
Materials and Methods

Materials
All cell culture reagents were purchased through Gibco-BRL (Gaithersburg, MD) unless otherwise indicated. Antibodies against
In the present study, the pathways involved in oxidantinduced cell death of a primary cell of the retina, ARPE-19, were investigated and compared with a leukemic cell, U937 cells. Both ARPE-19 and U937 cells exhibited similar viability when exposed to menadione. At lethal doses, both cell lines demonstrated extensive membrane blebbing. However, although U937 cells exhibited caspase-3, -9 PARP cleavage and 200 bp laddering, no such cleavage or laddering was noted in ARPE-19 cells. Furthermore, addition of exogenous cytochrome c and ATP to a cell-free system again resulted in cleavage of caspase-3 and -9 in extracts of U937 but not ARPE cells. Further studies in ARPE-19 cells undergoing menadione-induced cell death demonstrated mitochondrial membrane depolarization, release of cytochrome c, nuclear translocation of apoptosisinducing factor and subsequent 50 kilo-base pair laddering, and nuclear shrinkage. All of these findings were abrogated by the pretreatment of ARPE-19 cells with hepatocyte growth factor/scatter factor. These findings demonstrate the complex nature of cell death in primary cells of the retina and highlight the role of caspaseindependent signals, growth factors and intracellular survival factors in programmed cell death pathways.
caspase 3 (Chemicon, Temecula, California), PARP (Roche, Indianapolis, IN), cytochrome c (BD-Pharmingen, Palo Alto, CA), AIF, Oct-1 (Santa Cruz Biotechnologies, Santa Cruz, CA) and cytochrome c oxidase II (Molecular probes, Eugene, CA) were used. Anti-caspase-9 antibody was a kind gift of Y. Lazebnik (Cold Spring Harbor Laboratories, Cold Spring Harbor, NY) and X. Wang (University of Texas Southwestern, Dallas, TX). Trans-retinoic acid and menadione were obtained from Sigma (St. Louis, MO), Z-VAD.fmk was from Enzyme Systems Inc. (Dublin, CA) and recombinant HGF/SF was from R&D systems (Minneapolis, MN). Human leukemic U937 cells were obtained from ATCC (Manassas, VA), primary human RPE cells were generated as described previously (Sullivan et al., 1996) and human ARPE-19 cells, a human RPE cell line, were kindly provided by Leonard Hjelmeland (University of California, Davis, CA).
Cell culture ARPE-19 and primary human RPE cells were maintained in Dulbecco's modified Eagle's medium -Ham's F12 1:1 (DMEM/F12) supplemented with 10% fetal bovine serum (FBS) with 100 u/ml of penicillin and streptomycin. For all experiments ARPE-19 and human RPE cells were plated at confluence and allowed to differentiate in DMEM/F12 media supplemented with 1% FBS and 25 nM transretinoic acid without antibiotics for a minimum of 15 days. The human leukemic U937 cells were grown in suspension in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 10 mM HEPES, 4.5g/l glucose and 1.0 mM sodium pyruvate. For all treatments, cells were used at a density of 0.5 million cells/ml. RPE membrane blebbing 2×10 4 ARPE-19 cells stably expressing green fluorescent protein (GFP) targeted to the inner leaflet of the plasma membrane (ARPE-GFP-c′-rRas) were generated as described previously (Strunnikova et al., 2001) and seeded onto collagen-IV-coated eight-well chamber slides (LAB-TEK, Nalge Nunc International, Naperville, IL). After exposure to menadione, cells were fixed in 4% paraformaldehyde and examined under a dualchannel laser scanning confocal microscope (Leica, Exton, PA).
Cell viability assay (XTT assay) U937 cells or ARPE-19 cells (1×10 4 ) were seeded in 96-well microculture plates and treated with various doses of menadione. The number of surviving cells was measured by the XTT-{sodium 3′-[(1-phenylaminocarbonil)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate} assay (Cell Proliferation Kit II; Roche Molecular Biochemicals, Indianapolis, IN) following a 24 hour recovery period.
Western blot analysis
Crude cell extract was obtained as previously described (Strunnikova et al., 2001) with the following minor modification. Briefly, cells were lysed in 33.3 mM glucose, 33.3 mM Tris-HCl, pH 8, 6.7 mM EDTA, 2 M urea, 2% 2-mercaptoethanal, 1% SDS, supplemented with protease inhibitors (Complete-Mini; Roche Molecular Biochemical, Indianapolis, IN) by repetitive disruption through a 20-gauge needle. The lysate was centrifuged at 12,000 g for 15 minutes at 4°C, and the protein concentration in the supernatant was determined using a protein assay kit (Protein Assay Reagent kit; Pierce, Rockford, IL). Proteins were separated on a 10% SDS-polyacrylamide gel (Nupage; Invitrogen, Carlsbad, CA), transferred to a nitrocellulose filter (Millipore, Bedford, MA), stained with an appropriate antibody and developed by chemiluminescence (Western blot analysis kit, Roche Molecular Biochemica, Indianapolis, IN). The blots were exposed to Xray film (X-OMAT AR; Eastman Kodak, Rochester, NY) and the image was processed using Adobe Photoshop (Adobe System, Mountain View, CA).
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Isolation of subcellular fractions
Nuclei-free, mitochondria-free cytosolic extracts were prepared as described previously (Ellerby et al., 1997) . Briefly, cells were swelled in buffer A (50 mM PIPES, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM DTT plus of protease inhibitors) and gently disrupted with a Dounce homogenizer. The cell lysate was centrifuged for 30 minutes at 16,000 g at 4°C and the clarified supernatant was collected. Mitochondial fraction was prepared as described elsewhere (Martin et al., 1995) . Cells were suspended in buffer B [250 mM sucrose, 20 mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, cocktail of protease inhibitors] and gently disrupted by passing through an ice-cold cell homogenizer. Unlysed cells and nuclei were pelleted (750 g) for 10 minutes. The supernatant was further centrifuged (22,000 g) for 15 minutes and the pellets containing mitochrondria were collected and lysed. The cellular debris was removed by centrifugation (22,000 g) for 15 minutes. The supernatants containing mitochondrial proteins were collected. Nuclei were prepared as reported previously (Lazebnik et al., 1993) . Briefly, the cells were allowed to swell and lysed on ice in nuclear buffer (NB) (1 mM PIPES, pH 7.4, 10 mM KCl, 2 mM MgCl2, 1 mM DTT, 10 µM cytochalasin B and cocktail of protease inhibitors). The resulting homogenate was layered over 30% sucrose in NB. The nuclei were pelleted by centrifugation (800 g) for 10 minutes. For caspase activation, the 16,000 g cytosolic extract was incubated with 10 µM cytochrome c (Sigma, St. Louis, MO) and 1 mM dATP for 2 hours at 37°C.
Immunocytochemistry Differentiated ARPE cells were grown on eight-well chamber slides (Lab-Tek) and treated as previously described. Cells were fixed in methanol:acetone 50:50 (vol/vol) for 10 minutes at -20°C and blocked in 10% normal donkey serum containing 0.6% Triton X-100 in phosphate buffer (PBS) (pH 7.4) for 1 hour at room temperature. Slides were incubated with anti-AIF antibody and were then treated with Cy2-conjugated secondary antibody (Jackson ImmunoResearch). The cells were mounted with DAPI containing anti-fade mounting medium (Vectashield, Vector Laboratories, Inc. Burlingame, CA) and viewed with an epi-fluorescence microscope (Olympus Optical Co., LTD, Melville, NY) equipped with a cooled charge-coupled device camera. Images were digitally captured using NIH Image 1.52 software and recompiled in Adobe Photoshop (Adobe System, San Jose, CA). For negative controls, the slides were incubated with 10% normal donkey serum containing 0.6% Triton X-100 instead of the primary antibody and showed a lack of specific immunoreactivity. 
Results
Cell viability and caspase activation
Viability of ARPE-19 cells, a human retinal pigment epithelial cell line, and U937 cells, a leukemic cell line, following exposure to menadione, (Vitamin K3; 2-methyl-1,4-naphthoquinone) was determined using a colormetric dye-XTT-based assay. The dose responsiveness of both cell types was comparable (Fig. 1A) . The morphological characteristics of cell death, such as cell shrinkage and prominent cell membrane blebbing, were also similar in both cell types (Fig.  1B) . The extensive membrane blebbing was confirmed in ARPE-GFP-rRas cells, an ARPE-19 cell line genetically engineered to express GFP in the inner leaflet of the plasma membrane ( Fig. 1B) and showed protrusions and detachments of cell membrane blebs. Fig. 2 . Detection of caspase cleavage in whole cells and cell-free extracts. (A) 50-100 µg of whole lysates of U937 and ARPE-19 cells were analyzed by western blotting using antibodies against both pro-and cleaved forms of caspase-9 (top), -3 (middle) and PARP (bottom) in control cells and 4 hours after exposure to 50 µM menadione.
(B) Cytosolic extracts of 5×10 4 cells were prepared as described in Materials and Methods, incubated with 10 µM of cytochrome c and 1 mM ATP for 37°C for 2 hours, separated on a reducing gel and analyzed by western blotting using antibodies against caspase-9 (top) and -3 (bottom). (C) ARPE-19 cells were preincubated with Z-VAD.fmk (100 µM) for 1 hour and exposed to various concentrations of menadione (1 µM to 100 µM) for 2 hours. Cell viability was determined using the XTT assay as indicated in Fig.1A . (ᮀ), menadione alone; (᭛), menadione with Z-VAD.fmk.
To elucidate the biochemical pathways of RPE cell death, cells were exposed to a lethal dose (50 µM) of menadione and comparisons were made to U937 cells, a cell line that uses a caspase-3-dependent pathway for cell death. Both ARPE and U937 cells express caspases-3 and -9 as 32 kDa and 48 kDa proforms, respectively, and the 112 kDa effector molecule, poly-ADP-ribose polymerase (PARP) (Fig. 2A) . Induction of cell death in U937 cells resulted in the cleavage, at 4 hours, of caspase-3 to its reactive fragments of 19 kDa and 17 kDa and caspase-9 to its reactive fragments of 37 kDa and 35 kDa ( Fig.  2A) . Similarly, PARP cleavage to an 85 kDa fragment was also detected.
However, under similar conditions, in ARPE-19 cells no cleavage of caspase-3 or -9 was detected ( Fig. 2A) . Additionally, PARP remained intact.
When applying a broad-spectrum caspase inhibitor, Z-VAD.fmk, to ARPE-19 cells and exposing them to increasing doses of menadione, cell death was not attenuated as determined by the XTT assay (Fig. 2C) , reinforcing the concept that caspases are not involved in decisive steps of ARPE-19 cell death induced by menadione.
Cell free system
To further explore the state of caspase activation in ARPE-19 cell death and to ensure that depletion of ATP or excessive generation of ROS was not responsible for the inhibition of the caspases, an in-vitro cell system, using cystolic fractions of ARPE-19 and U937 cells, was studied. Previous studies have shown that caspases can be activated when cytosol from nonapoptotic cells is incubated with cytochrome c and ATP at 37°C (Ellerby et al., 1997) . Initial experiments (Fig. 2B) were performed to characterize this process in cytosol prepared from U937 cells. Incubation of purified cytosol with 1 mM ATP and 10 µM cytochrome c led to both caspase-3 and -9 activation. Processing of endogenous procaspase-3 was demonstrated by immunoblotting, which showed the appearance of a 17 kDa fragment (Fig. 2B) . Similarly, procaspase-9 was detected and in the presence of cytochrome c, it was processed into 35 and 37 kDa forms (Fig. 2B) .
Cytosol from ARPE-19 cells was prepared in a similar fashion to U937 cytosol. Western blot analysis revealed the presence of both caspase-3 and -9 in the fraction (Fig. 2B) . However, following addition of cytochrome c and ATP no cleavage of these caspases could be detected (Fig. 2B ) regardless of the amount of cytochrome c added or the time of incubation (data not shown), indicating that cytochrome-cdependent programmed cell death pathways are not active in ARPE-19 cells. Results obtained from a primary cell line of human retinal pigment epithelial cells indicated a similar pattern with the absence of caspase-3 cleavage noted in the presence of cytochrome c (Fig. 2B) .
DNA fragmentation
Detection of nuclei changes by using the DNA-binding dye DAPI in U937 and ARPE-19 cells 6 hours after exposure of a minimally lethal dose of menadione (50 µM) revealed marked differences between these two cell types. Typically, several stages of nuclear change can be seen during programmed cell death, with the formation of nuclear bodies as the end result.
This finding was evident in apoptotic U937 cells (Fig. 3A) where the nuclei showed typical condensed chromatin. However, ARPE-19 cells demonstrated only nuclear shrinkage (Fig. 3A) , similar to that seen in stage I nuclear changes. This type of change can also be seen in nuclei exposed to AIF (Daugas et al., 2000b) . Upon further examination, nuclear DNA from apoptotic U937 cells 6 hours after 50 µM menadione treatment showed internucleosomal 200 bp fragment laddering typical of programmed cell death (Fig. 3B ). In contrast, nuclear DNA from ARPE-19 cells under similar conditions did not demonstrate this 200 bp laddering (Fig. 3B) ; instead, cleavage to 50 kbp fragments, detected only by pulsefield electrophoresis (Fig. 3C) , was observed. This phenomenon is also typical of that seen in cells undergoing AIF-dependent DNA fragmentation. 200 bp fragment laddering was not seen in ARPE-19 cells at later time points (24 hours) or with higher doses of menadione (data not shown).
Journal of Cell Science 116 (10) Fig. 3 . Nuclear changes in apoptotic cells. (A) Following exposure to 50 µM menadione for 6 hours, cells were fixed in 4% paraformaldehyde for 5 minutes and put on a coverslip with DAPIcontaining mounting media and observed under epi-flurorescent microscopy. Bar, 10 µm. (B) 10 µg genomic DNA from U937 and ARPE-19 cells exposed to 50 µM menadione for 6 hours was separated either by 1.0% agarose gel electrophoresis (left) or pulse field gel electrophoresis (right) and visualized under UV illuminescence.
AIF translocation
In control ARPE-19 cells, mitochondria maintain a transmembrane potential (∆Ψm) that can be visualized by the membrane potential sensitive dye, CMXRos (Fig. 4A) . Immunofluorescence detection of AIF, found in >90% of cells, yielded a punctate cytoplasmic staining pattern with some preference for the perinuclear area, which is typical for mitochondrial localization with sparing of the nucleus. Merged images confirmed this localization. 4 hours after a lethal dose of menadione (50 µM) there was a loss of ∆Ψ m verified by the absence of CMXRos staining (Fig. 4A) , with subsequent translocation of AIF into the nucleus as demonstrated by colocalization of AIF immunostaining with DAPI, resulting in nuclear staining in >90% of cells. The frequency of cells demonstrating both loss of ∆Ψm and AIF translocation at 4 hours (Fig. 4C ) indicated a close correlation between these two events.
Western blot analysis of whole cell lysate, nuclear and mitochondrial fractions was used to track the intracellular movement of both AIF and cytochrome c in ARPE-19 cells 4 hours after exposure to 50 µM menadione. Both the 57 kDa AIF and the 15 kDa cytochrome c were detected in control ARPE-19 cells (Fig. 4B) . After the onset of programmed cell death, the 57 kDa AIF was found at a low level in mitochondria but appeared in the nuclear fractions. Cytochrome c was also translocated, as is typically seen with loss of ∆Ψm, from the mitochondria into the cytosol (Fig. 4B) .
Inhibition of AIF translocation HGF/SF protects epithelial cells and tumor cells against programmed cell death by inhibiting the loss of mitochondriapermeability transition and preventing the subsequent release of AIF and cytochrome c. The XTT assay of cell viability was used to measure the effect of HGF/SF pretreatment on menadione-induced toxicity of ARPE-19 cells. HGF/SF pretreatment increased significantly the LD90 concentration from 25 µM to 75 µM menadione (P<0.001) (Fig. 5A) . Redistribution of AIF in ARPE-19 cells treated with 50 µM menadione alone or with pre-treatment with HGF/SF was studied by using AIF-specific immunofluorescense. Compared with cells exposed to 50 µM menadione alone (Fig. 4A) , pretreatment with HGF/SF prevented ∆Ψm depolarization, as demonstrated by maintenance of CMXRos staining (Fig. 5C) . Additionally, AIF remained within the mitochondria of cells and no changes in nuclear appearance could be detected. The frequency of cells demonstrating AIF nuclear distribution was also determined: whereas >90% of cells exposed to menadione (50 µM) alone exhibited nuclear AIF, pretreatment with HGF/SF completed abrogated this phenomenon (Fig. 5B) .
Prevention of AIF redistribution as a possible mechanism of HGF/SF survival in ARPE-19 cells exposed to menadione was further confirmed by examining AIF nuclear translocation using western blot analysis (Fig. 6) . Nuclear fractions of ARPE-19 cells pretreated with HGF/SF and exposed to 50 µM menadione showed an absence of AIF in the nuclear fractions compared to cells treated with menadione alone. Detection of the nuclear protein, Oct-1, confirmed the presence of equivalent amounts of protein in the fractions. Additionally, 50 kbp sized DNA fragments were also not seen in nuclear DNA from cells pretreated with HGF/SF. However, this fragmentation was observed only in cells treated with menadione alone (Fig. 6) . These results further reinforce the concept that prevention of AIF nuclear translocation and subsequent DNA damage are keys steps in HGF/SF protection in ARPE-19 cells exposed to lethal doses of menadione.
Discussion
Cell death, brought about by activation of the PCD pathway, appears to play a prominent role in chronic degenerative diseases, such as Alzheimer's and Parkinson's disease and agerelated macular degeneration (Hinton et al., 1998; Thompson, 1995) . Therefore, the understanding and control of PCD pathways may provide a way to delay or prevent the onset of these diseases. The PCD pathway that has been most studied involves the release of mitochondrial cytochrome c, which results in activation of the caspase cascade and DNA fragmentation. Although alternative PCD pathways exist, their control over cell death is poorly understood . In particular, AIF-mediated cell death appears to play a principal role only in genetically altered cells or in the setting of exogenous caspase inhibition (Dumont et al., 2000; Joza et al., 2001; Loeffler et al., 2001; Susin et al., 2000; Susin et al., 1999; Yasugi et al., 2000) . The present study provides evidence that a primary line of RPE cells suppresses activation of Journal of Cell Science 116 (10) caspases in the presence of cytoplasmic cytochrome c and utilizes, instead, an alternative mechanism of AIF release as a principle initiator of PCD.
PCD has both cellular and biochemical features. Cells undergoing PCD typically shows signs of cell shrinkage, membrane blebbing and nuclear condensation. Classic PCD biochemical pathways typically revolve around mitochondrial membrane depolarization, with subsequent release of cytochrome c from the mitochondria. Cytoplasmic cytochrome c forms a complex, termed the apoptosome, with caspase-9 and Apaf-1, which results in the cleavage of caspase-9 into an active 35 kDa active fragment, which subsequently cleaves caspase-3 (Li et al., 1997) . The active 17 kDa fragment of caspase-3 further activates effector molecules leading to DNA fragmentation. The prominence of this PCD pathway in various cell types supports the use of caspase inhibitors to delay cell death in several disease states. The role of alternative PCD pathways, such as release of AIF, AMID or activation of cathepsins, is still unclear . AIF, a 57kDa flavoprotein, is targeted to the mitochondria where it is found in the intermembrane space of the mitochondria (Daugas et al., 2000a) . Recent evidence suggests that intact activated PARP may be required for AIF release from the mitochondria (Yu et al., 2002) . Although PARP activation was not directly measured in the present study, the absence of PARP cleavage in ARPE-19 cells following lethal injury assures its availability to induce AIF release. AIF subsequently translocates to the nucleus where it results in DNA fragmentation producing large fragments (50 kbp) through an unknown pathway (Susin et al., 1999) . This form of DNA fragmentation can also result in TUNEL-positive cell staining. Although it appears that AIF can be co-released with other mitochondria proteins in cells undergoing PCD, no evidence exists of its utility as a primary mechanism of cell death in adult cells. The majority of studies have implicated AIF involvement in the early stages of apoptosis, where it is responsible for stage 1 chromatin condensation. AIF release also propagates apoptosis by affecting the barrier function of mitochondria, resulting in the release of cytochrome c and AIF from other mitochondria (Daugas et al., 2000b; Loeffler et al., 2001; Susin et al., 1999) . In the present study, 4 hours after a lethal injury, essentially all ARPE-19 cells demonstrating AIF nuclear translocation had lost their mitochondrial membrane potential. Interestingly in lymphocytes AIF release in the absence of caspase activation does not lead to cell death (Dumont et al., 2000) .
Menadione is a quinone that generates intracellular reactive oxygen species (ROS) that result in mitochondrial membrane depolarization with subsequent activation of caspasedependent PCD (Gerasimenko et al., 2002) , as was seen in this study in U937 cells. Menadione at high doses (250 µM) can indirectly inhibit caspase activity through a reduction in ATP levels (Leist et al., 1997) or through the generation of high intracellular levels of ROS (Samali et al., 1999) . However, in both U937 and ARPE cells, menadione at 50 µM induced features of apoptosis, including membrane blebbing and DNA fragmentation. Interesting, AIF-knockout cells (aif --/Y ES) survived in the presence of 150 µM menadione but only when Z-VAD.fmk was added (Joza et al., 2001) , indicating that AIF is one of the pathways in menadione-induced cell death and further suggesting that menadione acts in a redundant fashion through both the caspases and AIF.
Several previous studies of oxidant-induced RPE cell death have focused on indirect evidence of caspase-3 activation through the use of TUNEL staining (Barak et al., 2001; Osborne et al., 1997) . Other investigators have demonstrated the disappearance of total cellular caspase-3 (Cai et al., 1999) , an observation that is an imprecise measure of caspase activation. Under the influence of complete zinc depletion (Wood and Osborne, 2001) , direct evidence of caspase-3 fragmentation has been shown in the RPE cells, but this is in stringent conditions that may have little relevance to the normal state of these cells (Chai et al., 1999; Hyun et al., 2001) . A2E activation by blue light activates fluorescenic caspase-3 chromophorbes (Sparrow and Cai, 2001; Sparrow et al., 2002; Suter et al., 2000) but direct detection of caspase-3 fragments has not been presented.
The molecular pathways connecting the biochemical and cellular changes observed in PCD are still under investigation. Under typical conditions of caspase-3 activation, membrane blebbing occurs through the cleavage of ROCK1, leading to phosphorylation of myosin light chains (Coleman et al., 2001; Sebbagh et al., 2001) . In our study, AIF release without caspase activation still produced blebbing. Whether these PCD and cell membrane blebbing pathways can be activated independently Fig. 6 . HGF/SF effects on AIF nuclear distribution and large scale DNA fragmentation. Nuclear extracts were analyzed by western blotting for AIF (top) obtained 6 hours following either no treatment or treatment with HGF/SF (50 ng/ml for 48 hours) and menadione (50 µM for 2 hours). The blot was stripped and re-blotted with antiOct-1 antibody (middle) to normalize for protein loading. Pulse field gel electrophoresis was performed (as described in Materials and Methods) on 10 µg of genomic DNA from ARPE-19 cells exposed to similar conditions (bottom).
is still controversial, but clearly the present data confirm previous reports that caspase activation is not required for some of the cellular changes associated with PCD (Foghsgaard et al., 2001) .
The present study provides evidence that RPE cells possess protective mechanisms to guard against inadvertent caspase activation even in the presence of cytochrome c release. Heat shock protein 27 (Hsp27) is abundant in RPE cells (Strunnikova et al., 2001) and appears to interfere with processing of caspase-9 cleavage during apoptosome assembly (Bruey et al., 2000; Garrido et al., 1999) . ATP depletion also inhibit caspase activation (Leist et al., 1997) but in the present study, using a cell free assay, ATP was not rate limiting. Of interest is recent work that has indicated that Hsp70 binds to AIF and prevents its activation (Ravagnan et al., 2001) . Future work on PCD in RPE cells will focus on the use of this protein as a possible protective factor in oxidant-induced cell death.
Growth factor control of PCD is an emerging field of study. RPE cells possess c-Met, the receptor for HGF-SF (Lashkari et al., 1999) . A prominent source of HGF-SF in vivo in the retina may be macrophages normally found in the tissue surrounding the RPE and recruited in AMD (Killingsworth et al., 1990) . The results in this study confirm previous findings about the ability of HGF/SF to affect apoptosis (Gao et al., 2001; Mildner et al., 2002) .
In the activation of oxidant-induced RPE cell death, a process which has been postulated to play a role in the terminal events of atrophic AMD, it is becoming clear that a complex interaction of pro-PCD signals and the presence of anti-PCD proteins determines the fate of the cell. Discovering what controls the balance of these two opposing forces is the focus of ongoing work.
